- Home
- VXRT vs HRTX Comparison
VXRT vs HRTX Comparison
Compare VXRT & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VXRT
- HRTX
- Stock Information
- Founded
- VXRT N/A
- HRTX 1983
- Country
- VXRT United States
- HRTX United States
- Employees
- VXRT N/A
- HRTX N/A
- Industry
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- VXRT Health Care
- HRTX Health Care
- Exchange
- VXRT Nasdaq
- HRTX Nasdaq
- Market Cap
- VXRT 200.3M
- HRTX 229.7M
- IPO Year
- VXRT N/A
- HRTX 1987
- Fundamental
- Price
- VXRT $0.76
- HRTX $1.63
- Analyst Decision
- VXRT Strong Buy
- HRTX Strong Buy
- Analyst Count
- VXRT 2
- HRTX 3
- Target Price
- VXRT $3.00
- HRTX $5.67
- AVG Volume (30 Days)
- VXRT 2.6M
- HRTX 1.6M
- Earning Date
- VXRT 03-13-2025
- HRTX 03-11-2025
- Dividend Yield
- VXRT N/A
- HRTX N/A
- EPS Growth
- VXRT N/A
- HRTX N/A
- EPS
- VXRT N/A
- HRTX N/A
- Revenue
- VXRT $16,760,000.00
- HRTX $137,737,000.00
- Revenue This Year
- VXRT $128.77
- HRTX $13.10
- Revenue Next Year
- VXRT N/A
- HRTX $18.76
- P/E Ratio
- VXRT N/A
- HRTX N/A
- Revenue Growth
- VXRT 303.27
- HRTX 12.13
- 52 Week Low
- VXRT $0.52
- HRTX $1.04
- 52 Week High
- VXRT $1.54
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- VXRT 55.26
- HRTX 53.74
- Support Level
- VXRT $0.70
- HRTX $1.46
- Resistance Level
- VXRT $0.83
- HRTX $1.58
- Average True Range (ATR)
- VXRT 0.09
- HRTX 0.10
- MACD
- VXRT -0.00
- HRTX -0.00
- Stochastic Oscillator
- VXRT 36.62
- HRTX 45.95
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.